The impact of Limosilactobacillus reuteri in combination with non-surgical periodontal therapy on periodontal clinical parameters and salivary and subgingival microbiota composition in individuals with stage III–IV periodontitis: a randomized control
The trial was approved by the Chinese Clinical Trial Registry (ChiCTR) on March 25, 2021, with registration number ChiCTR2100044638.
Authors
- Lijun Luo (ORCID: https://orcid.org/0000-0002-1578-4106)
- Pengcheng Huo (ORCID: https://orcid.org/0009-0009-2181-6395)
- Peiyi Kan (ORCID: https://orcid.org/0000-0002-5079-756X)
- Jiawei Lu (ORCID: https://orcid.org/0000-0001-8003-2114)
- Rui Jing (ORCID: https://orcid.org/0009-0001-2039-839X)
- Li Deng (ORCID: https://orcid.org/0000-0002-7742-0826)
Institutions
- Shanghai Stomatological Hospital (CN)
Publication Details
- Journal
- BMC Oral Health
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1186/s12903-025-06084-1
- Citations
- 6
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 8.79
Funders
- Shanghai Municipal Health Commission
- Science and Technology Commission of Shanghai Municipality